| Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo … ME Santolaya, ML O'Ryan, MT Valenzuela, V Prado, R Vergara, A Muñoz, ... The Lancet 379 (9816), 617-624, 2012 | 332 | 2012 |
| Clinical presentation of Bacillus Calmette-Guerin infections in patients with immunodeficiency syndromes. B Gonzalez, S Moreno, R Burdach, MT Valenzuela, A Henriquez, ... The Pediatric infectious disease journal 8 (4), 201-206, 1989 | 142 | 1989 |
| SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study JP Torres, C Piñera, V De La Maza, AJ Lagomarcino, D Simian, B Torres, ... Clinical infectious diseases: an official publication of the Infectious …, 2020 | 132* | 2020 |
| The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence MT Valenzuela, R O'Loughlin, F De La Hoz, E Gomez, D Constenla, ... Revista Panamericana de Salud Pública 25, 270-279, 2009 | 123 | 2009 |
| Los QALYs y DALYs como indicadores sintéticos de salud N Alvis, MT Valenzuela Revista médica de Chile 138, 83-87, 2010 | 116 | 2010 |
| Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile R Lagos, A Muñoz, MT Valenzuela, I Heitmann, MM Levine The Pediatric infectious disease journal 21 (12), 1115-1123, 2002 | 96 | 2002 |
| Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile M O’RYAN, Y Lucero, A Peña, MT Valenzuela The Pediatric infectious disease journal 22 (8), 717-721, 2003 | 92 | 2003 |
| Persistence of antibodies in adolescents 18− 24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine ME Santolaya, M O'Ryan, MT Valenzuela, V Prado, RF Vergara, A Muñoz, ... Human vaccines & immunotherapeutics 9 (11), 2304-2310, 2013 | 89 | 2013 |
| Importancia de las vacunas en salud pública: hitos y nuevos desafíos MT Valenzuela Revista Médica Clínica Las Condes 31 (3), 233-239, 2020 | 81 | 2020 |
| Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens R Lagos, MT Valenzuela, OS Levine, GA Losonsky, A Erazo, ... The Lancet 351 (9114), 1472-1476, 1998 | 80 | 1998 |
| Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis A Sinha, D Constenla, JE Valencia, R O'Loughlin, E Gomez, F de la Hoz, ... Revista Panamericana de Salud Pública 24, 304-313, 2008 | 75 | 2008 |
| Cost-effectiveness of universal childhood hepatitis A vaccination in Chile MT Valenzuela, RJ Jacobs, O Arteaga, MS Navarrete, AS Meyerhoff, ... Vaccine 23 (32), 4110-4119, 2005 | 74 | 2005 |
| The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean D Constenla, E Gomez, FP de la Hoz, R O’Loughlin, A Sinha, JE Valencia, ... Sabin Vaccine Institute 1, 129, 2007 | 68 | 2007 |
| ¿ Por qué no me hago el Papanicolau?: barreras sicológicas de mujeres de sectores populares de Santiago de Chile MT Valenzuela, A Miranda Rev. chil. salud pública, 75-80, 2001 | 64 | 2001 |
| Perspectives on battling COVID-19 in countries of Latin America and the Caribbean JK Andrus, T Evans-Gilbert, JI Santos, MG Guzman, PJ Rosenthal, ... The American journal of tropical medicine and hygiene 103 (2), 593, 2020 | 63 | 2020 |
| Prevalencia de hipertensión arterial y su asociación con la obesidad en edad pediátrica R Bancalari, C Díaz, A Martínez-Aguayo, M Aglony, J Zamorano, V Cerda, ... Revista médica de Chile 139 (7), 872-879, 2011 | 62 | 2011 |
| Cambio climático y enfermedades infecciosas: un nuevo escenario epidemiológico J Cerda, G Valdivia, MT Valenzuela, J Venegas Revista chilena de infectología 25 (6), 447-452, 2008 | 62 | 2008 |
| Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines R Villena, MAP Safadi, MT Valenzuela, JP Torres, A Finn, M O'Ryan Human vaccines & immunotherapeutics 14 (5), 1042-1057, 2018 | 60 | 2018 |
| Indicadores de Salud: características, uso y ejemplos MT Valenzuela, M Teresa Ciencia & Trabajo 17, 118-122, 2005 | 55 | 2005 |
| Effectiveness of the 10-valent pneumococcal conjugate vaccine (PCV-10) in children in Chile: a nested case-control study using nationwide pneumonia morbidity and mortality … J Diaz, S Terrazas, AL Bierrenbach, CM Toscano, GP Alencar, A Alvarez, ... PLoS One 11 (4), e0153141, 2016 | 52 | 2016 |
